Clinical trial

Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma

NCT00384826

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE2

Study timeline

Study start (unknown)2006-09-01Date precision: month

Registry last updated2015-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adenocarcinoma, Bronchiolo-Alveolarunresolved

Interventions

erlotinibDRUG · verified · RxNorm: erlotinib

paclitaxel + carboplatineDRUG

Sponsors & collaborators

Intergroupe Francophone de Cancerologie Thoraciquelead sponsor

Mapped research locations

ParisFrance2 CaenFrance2 StrasbourgFrance1 GrenobleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00384826 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.